董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Suren Ajjarapu | 男 | Chairman, Chief Executive Officer and Secretary | 52 | 38.84万美元 | 未持股 | 2023-04-24 |
| Prashant Patel | 男 | Director, President, Chief Operating Officer and Chief Financial Officer | 49 | 15.00万美元 | 未持股 | 2023-04-24 |
| Donald G. Fell | 男 | Director | 77 | 9.63万美元 | 未持股 | 2023-04-24 |
| Michael L Peterson | 男 | Director | 60 | 9.63万美元 | 未持股 | 2023-04-24 |
| Jeff Newell | 男 | Director | 65 | 未披露 | 未持股 | 2023-04-24 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Suren Ajjarapu | 男 | Chairman, Chief Executive Officer and Secretary | 52 | 38.84万美元 | 未持股 | 2023-04-24 |
| Prashant Patel | 男 | Director, President, Chief Operating Officer and Chief Financial Officer | 49 | 15.00万美元 | 未持股 | 2023-04-24 |
董事简历
中英对照 |  中文 |  英文- Suren Ajjarapu
-
自招股说明书构成部分的注册声明生效之日起,Suren Ajjarapu一直担任我们的董事之一。Ajjarapu自2010年7月起担任TrxadeGroup,Inc.(NASDAQ:MEDS,特拉华州一家公司及其前身公司)董事长、首席执行官和秘书。自2018年3月以来,Ajjarapu先生一直担任Kano Energy Corp.的董事会执行主席,该公司参与了美国可再生天然气站点的开发。Ajjarapu先生是Sansur Renewable Energy,Inc.的创始人,并于2009年3月至2012年12月担任首席执行官兼董事会主席,Sansur Renewable Energy,Inc.是一家参与开发美国中西部风电站点的公司。Ajjarapu先生还从2006年1月到2009年3月担任Aemetis,Inc.(一家生物燃料公司,纳斯达克股票代码:AMTX)的创始人、总裁兼董事,以及International Biofuels(Aemetis,Inc.的一家子公司)的创始人、董事长兼首席执行官。Ajjarapu先生是Global Information Technology,Inc.的联合创始人,首席运营官兼董事,Global Information Technology,Inc.是一家IT外包和系统设计公司,总部位于佛罗里达州坦帕,在印度拥有主要业务。Ajjarapu先生毕业于南达科他州立大学,获得环境工程硕士学位,并毕业于南佛罗里达大学,获得国际金融和管理专业的工商管理硕士学位。Ajjarapu先生还是哈佛大学风险资本和私募股权计划的毕业生。
Suren Ajjarapu has served as Aesther Healthcare Acquisition Corp.'s Chairman and Chief Executive Officer since Aesther Healthcare Acquisition Corp.'s inception in June 2021. He has served as the Chairman of the Board, Chief Executive Officer and Secretary of TRxADE HEALTH, INC., formerly Trxade Group, Inc. NASDAQ:MEDS("TRxADE") since its acquisition of Trxade Group, Inc., a Nevada corporation ("Trxade Nevada") (Aesther Healthcare Acquisition Corp.'s predecessor company) on January 8 2014 and as the Chairman of the Board, Chief Executive Officer and Secretary of Trxade Nevada since its inception. Since March 2021 Mr. Ajjarapu has served on the Board of OceanTech Acquisitions I Corp., a Special Purpose Acquisition Company (SPAC)(NASDAQ:OTECU). Mr. Ajjarapu was a Founder, CEO and Chairman of Sansur Renewable Energy, Inc., a company involved in developing wind power sites in the Midwest, United States, from 2009 to 2012. Mr. Ajjarapu was a Founder, President and Director of Aemetis, Inc., a biofuels company (AMTX.OB) and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis, Inc., from 2006 to 2009. Mr. Ajjarapu was Co-Founder, COO, and Director Global Information Technology, Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India from 1995 to 2006. Mr. Ajjarapu holds an MS in Environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University. - 自招股说明书构成部分的注册声明生效之日起,Suren Ajjarapu一直担任我们的董事之一。Ajjarapu自2010年7月起担任TrxadeGroup,Inc.(NASDAQ:MEDS,特拉华州一家公司及其前身公司)董事长、首席执行官和秘书。自2018年3月以来,Ajjarapu先生一直担任Kano Energy Corp.的董事会执行主席,该公司参与了美国可再生天然气站点的开发。Ajjarapu先生是Sansur Renewable Energy,Inc.的创始人,并于2009年3月至2012年12月担任首席执行官兼董事会主席,Sansur Renewable Energy,Inc.是一家参与开发美国中西部风电站点的公司。Ajjarapu先生还从2006年1月到2009年3月担任Aemetis,Inc.(一家生物燃料公司,纳斯达克股票代码:AMTX)的创始人、总裁兼董事,以及International Biofuels(Aemetis,Inc.的一家子公司)的创始人、董事长兼首席执行官。Ajjarapu先生是Global Information Technology,Inc.的联合创始人,首席运营官兼董事,Global Information Technology,Inc.是一家IT外包和系统设计公司,总部位于佛罗里达州坦帕,在印度拥有主要业务。Ajjarapu先生毕业于南达科他州立大学,获得环境工程硕士学位,并毕业于南佛罗里达大学,获得国际金融和管理专业的工商管理硕士学位。Ajjarapu先生还是哈佛大学风险资本和私募股权计划的毕业生。
- Suren Ajjarapu has served as Aesther Healthcare Acquisition Corp.'s Chairman and Chief Executive Officer since Aesther Healthcare Acquisition Corp.'s inception in June 2021. He has served as the Chairman of the Board, Chief Executive Officer and Secretary of TRxADE HEALTH, INC., formerly Trxade Group, Inc. NASDAQ:MEDS("TRxADE") since its acquisition of Trxade Group, Inc., a Nevada corporation ("Trxade Nevada") (Aesther Healthcare Acquisition Corp.'s predecessor company) on January 8 2014 and as the Chairman of the Board, Chief Executive Officer and Secretary of Trxade Nevada since its inception. Since March 2021 Mr. Ajjarapu has served on the Board of OceanTech Acquisitions I Corp., a Special Purpose Acquisition Company (SPAC)(NASDAQ:OTECU). Mr. Ajjarapu was a Founder, CEO and Chairman of Sansur Renewable Energy, Inc., a company involved in developing wind power sites in the Midwest, United States, from 2009 to 2012. Mr. Ajjarapu was a Founder, President and Director of Aemetis, Inc., a biofuels company (AMTX.OB) and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis, Inc., from 2006 to 2009. Mr. Ajjarapu was Co-Founder, COO, and Director Global Information Technology, Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India from 1995 to 2006. Mr. Ajjarapu holds an MS in Environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
- Prashant Patel
-
Prashant Patel,自Trxade Health,Inc.于2014年1月8日收购TRxADE Nevada以来,一直担任Trxade Health,Inc.的全职总裁兼首席运营官和董事。帕特尔先生是一名注册药剂师和制药顾问,在零售药房和医药物流领域拥有20多年的经验,是佛罗里达州坦帕湾地区几家药房的创始人。Patel先生自2010年8月起担任Trxade Nevada总裁兼董事会成员。自2008年10月以来,帕特尔先生一直担任制药公司APAA LLC的管理成员和制药逆向分销商Pharmaceutical Returns Of America LLC的首席执行官。Patel先生毕业于诺丁汉大学药学院,在联合王国执业,之后在联合王国城市大学卡斯商学院获得运输、贸易和金融硕士学位。
Prashant Patel,has served as Trxade Health, Inc. full-time President and Chief Operating Officer, and as a director since Trxade Health, Inc. acquisition of TRxADE Nevada on January 8, 2014. Effective March 6, 2023, Mr. Patel, was appointed as Interim Principal Financial/Accounting Officer of the Company following Ms. Janet Huffman's notification to the Company on February 27, 2023, of the termination of her Offer Letter dated February 3, 2022. Mr. Patel is a registered pharmacist and pharmaceutical consultant with over twenty years of experience in retail pharmacy and pharmaceutical logistics, and the founder of several pharmacies in the Tampa Bay, Florida area. Mr. Patel has been President and Member of Board of Trxade Nevada since August 2010. Since October 2008, Mr. Patel has been Managing Member of APAA LLC, a pharmacy and CEO of Pharmaceutical Returns Of America LLC, a pharmaceutical reverse distributor. Mr. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, United Kingdom. - Prashant Patel,自Trxade Health,Inc.于2014年1月8日收购TRxADE Nevada以来,一直担任Trxade Health,Inc.的全职总裁兼首席运营官和董事。帕特尔先生是一名注册药剂师和制药顾问,在零售药房和医药物流领域拥有20多年的经验,是佛罗里达州坦帕湾地区几家药房的创始人。Patel先生自2010年8月起担任Trxade Nevada总裁兼董事会成员。自2008年10月以来,帕特尔先生一直担任制药公司APAA LLC的管理成员和制药逆向分销商Pharmaceutical Returns Of America LLC的首席执行官。Patel先生毕业于诺丁汉大学药学院,在联合王国执业,之后在联合王国城市大学卡斯商学院获得运输、贸易和金融硕士学位。
- Prashant Patel,has served as Trxade Health, Inc. full-time President and Chief Operating Officer, and as a director since Trxade Health, Inc. acquisition of TRxADE Nevada on January 8, 2014. Effective March 6, 2023, Mr. Patel, was appointed as Interim Principal Financial/Accounting Officer of the Company following Ms. Janet Huffman's notification to the Company on February 27, 2023, of the termination of her Offer Letter dated February 3, 2022. Mr. Patel is a registered pharmacist and pharmaceutical consultant with over twenty years of experience in retail pharmacy and pharmaceutical logistics, and the founder of several pharmacies in the Tampa Bay, Florida area. Mr. Patel has been President and Member of Board of Trxade Nevada since August 2010. Since October 2008, Mr. Patel has been Managing Member of APAA LLC, a pharmacy and CEO of Pharmaceutical Returns Of America LLC, a pharmaceutical reverse distributor. Mr. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, United Kingdom.
- Donald G. Fell
-
Donald G. Fell,自2014年1月起担任Trxade Health,Inc.的独立董事。他目前是位于加利福尼亚州戴维斯的经济学教学基金会的教授和研究所主任,以及科罗拉多大学斯普林斯分校的经济学兼职教授。1995-2012年,费尔先生在南佛罗里达大学担任EMBA教员、行政和专业教育主任以及公共政策研究所高级研究员。他还曾在法国拉罗谢尔大学担任经济学客座教授,并在伊利诺伊州立大学和俄亥俄州立大学担任经济学兼职教授。费尔先生拥有印第安纳州立大学的经济学本科和研究生学位,并且几乎是伊利诺伊州立大学的经济学博士学位(ABD)。通过与经济学教学基金会和科罗拉多大学科罗拉多斯普林斯分校的合作,他在加拿大、群岛和东欧的44个州开设了经济政策和环境经济学研究生院。
Donald G. Fell,has served as an independent director of Trxade Health, Inc. since January 2014. He is presently Professor and Institute Director for the Davis, California-based Foundation for Teaching Economics and adjunct professor of economics for the University of Colorado, Colorado, Springs. From December 2022, Mr. Fell has served as a director of Kernel Group Holdings, Inc., a special purpose acquisition company (NASDAQ: KRNL). Since March 2023, Mr. Fell has also served as a director of OceanTech Acquisition I Corp,a special purpose acquisition company (NASDAQ: OTEC). From 1995 – 2012, Mr. Fell held positions with the University of South Florida as a member of the Executive MBA faculty, Director of Executive and Professional Education and Senior Fellow of the Public Policy Institute. He has also served as visiting professor of economics at the University of LaRochelle, France, and as adjunct professor of economics at both Illinois State University and The Ohio State University. Mr. Fell holds undergraduate and graduate degrees in economics from Indiana State University and is all but dissertation (ABD) in economics from Illinois State University. Through his work with the Foundation for Teaching Economics and the University of Colorado, Colorado Springs he has conducted graduate institutes on economic policy and environmental economics in 44 states, throughout Canada, the Islands and Eastern Europe. - Donald G. Fell,自2014年1月起担任Trxade Health,Inc.的独立董事。他目前是位于加利福尼亚州戴维斯的经济学教学基金会的教授和研究所主任,以及科罗拉多大学斯普林斯分校的经济学兼职教授。1995-2012年,费尔先生在南佛罗里达大学担任EMBA教员、行政和专业教育主任以及公共政策研究所高级研究员。他还曾在法国拉罗谢尔大学担任经济学客座教授,并在伊利诺伊州立大学和俄亥俄州立大学担任经济学兼职教授。费尔先生拥有印第安纳州立大学的经济学本科和研究生学位,并且几乎是伊利诺伊州立大学的经济学博士学位(ABD)。通过与经济学教学基金会和科罗拉多大学科罗拉多斯普林斯分校的合作,他在加拿大、群岛和东欧的44个州开设了经济政策和环境经济学研究生院。
- Donald G. Fell,has served as an independent director of Trxade Health, Inc. since January 2014. He is presently Professor and Institute Director for the Davis, California-based Foundation for Teaching Economics and adjunct professor of economics for the University of Colorado, Colorado, Springs. From December 2022, Mr. Fell has served as a director of Kernel Group Holdings, Inc., a special purpose acquisition company (NASDAQ: KRNL). Since March 2023, Mr. Fell has also served as a director of OceanTech Acquisition I Corp,a special purpose acquisition company (NASDAQ: OTEC). From 1995 – 2012, Mr. Fell held positions with the University of South Florida as a member of the Executive MBA faculty, Director of Executive and Professional Education and Senior Fellow of the Public Policy Institute. He has also served as visiting professor of economics at the University of LaRochelle, France, and as adjunct professor of economics at both Illinois State University and The Ohio State University. Mr. Fell holds undergraduate and graduate degrees in economics from Indiana State University and is all but dissertation (ABD) in economics from Illinois State University. Through his work with the Foundation for Teaching Economics and the University of Colorado, Colorado Springs he has conducted graduate institutes on economic policy and environmental economics in 44 states, throughout Canada, the Islands and Eastern Europe.
- Michael L Peterson
-
Michael L Peterson于2022年4月开始担任Lafayette Energy Corp.的总裁、首席执行官和董事会成员。自2021年9月起,Peterson先生担任Aesther Healthcare Acquisition Corp.(纳斯达克股票代码:AEHA)董事会、审计委员会(主席)、薪酬委员会、提名和公司治理委员会成员,该公司是一家与Ocean Biomedical公司(纳斯达克股票代码:OCEA)合并的特殊目的收购公司,并继续担任合并后公司的独立董事。自2022年12月起,Peterson先生还担任特殊目的收购公司Kernel Group Holdings, Inc.(纳斯达克股票代码:KRNL)的董事。自2023年3月起,Peterson先生还担任特殊目的收购公司OceanTech收购I Corp(纳斯达克股票代码:OTEC)的董事。彼得森自2020年12月起担任Nevo Motors,Inc.的总裁,该公司成立的目的是为重型电动汽车市场商业化增程发电机技术,但目前尚未投入运营。自2022年5月起,Peterson先生担任Trio Petroleum Corp.的董事会成员和审计委员会主席,Trio Petroleum Corp.是一家正在上市的石油和天然气勘探和开发公司,自2021年2月起,Peterson先生担任Indonesia Energy Corporation Limited(纽约证券交易所美国代码:INDO)的董事会成员和审计委员会主席。彼得森曾于2018年6月至2021年6月在台湾台北担任耶稣基督后期圣徒教会台北台湾传道会会长。Peterson先生于2016年8月至2021年5月担任TRxADE HEALTH公司(原Trxade Group, Inc.)董事会的独立成员(纳斯达克股票代码:MEDS)。彼得森先生于2016年5月至2018年5月担任PEDEVCO公司(纽约证券交易所美国代码:PED)的首席执行官,该公司是一家上市公司,主要从事石油和天然气页岩的收购、勘探、开发和生产。Peterson先生于2012年7月至2016年5月担任PEDEVCO的首席财务官,并于2012年7月至2014年10月担任太平洋能源开发公司(PEDEVCO的前身)的执行副总裁,并于2014年10月至2018年5月担任PEDEVCO的总裁。Peterson先生于2011年9月加入太平洋能源发展公司,担任执行副总裁,2012年6月担任首席财务官,并于2012年7月至2013年9月担任公司董事会成员。Peterson先生曾担任Pacific Energy Development的临时总裁兼首席执行官(2009年6月至2011年12月)和董事(2008年5月至2011年12月)、Aemetis, Inc.(原AE Biofuels Inc.)的董事(2006年5月至2012年7月),以及Nevo Energy,Inc.(NEVE)(原Solargen Energy,Inc.)的董事长兼首席执行官,Nevo Energy,Inc.是一家总部位于加利福尼亚州库比蒂诺的公用事业规模太阳能发电场开发商,他于2008年12月(2008年12月至2012年7月)帮助成立了这家公司。从2005年到2006年,彼得森先生担任美国机构伙伴公司的管理合伙人,这是一家设在盐湖城的风险投资基金。从2000年到2004年,他在美林担任第一副总裁,帮助建立了一个新的私人客户服务部门,专门与高净值投资者合作。1989年9月至2000年1月,Peterson先生受雇于高盛萨克斯公司,担任各种职务和职务,包括副总裁。Peterson先生在万豪酒店管理学院获得MBA学位,在杨百翰大学获得统计学/计算机科学学士学位。
Michael L Peterson,commenced serving as President, Chief Executive Officer and as a member of the Board of Directors of Lafayette Energy Corp. in April 2022. Since September 2021, Mr. Peterson has served as a member of the Board of Directors, Audit Committee (Chair), Compensation Committee and Nominating and Corporate Governance Committee of Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA), a special purpose acquisition company which merged with Ocean Biomedical, Inc (NASDAQ: OCEA) and continues to serve as an independent director of the merged company. Since December 2022, Mr. Peterson has also served as a director of Kernel Group Holdings, Inc., a special purpose acquisition company (NASDAQ: KRNL). Since March 2023, Mr. Peterson has also served as a director of OceanTech Acquisition I Corp,a special purpose acquisition company (NASDAQ: OTEC). Mr. Peterson has served as the president of Nevo Motors, Inc. since December 2020, which was established to commercialize a range extender generator technology for the heavy-duty electric vehicle market but is currently non-operational. Since May 2022, Mr. Peterson has served as a member of the Board of Directors and as the Chairperson of the Audit Committee of Trio Petroleum Corp., an oil and gas exploration and development company which is in the process of going public, since February 2021, Mr. Peterson has served on the board of directors and as the Chairman of the Audit Committee of Indonesia Energy Corporation Limited (NYSE American: INDO). Mr. Peterson previously served as the president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan from June 2018 to June 2021. Mr. Peterson served as an independent member of the Board of Directors of TRxADE HEALTH, Inc. (formerly Trxade Group, Inc.) from August 2016 to May 2021 (NASDAQ: MEDS). Mr. Peterson served as the Chief Executive Officer of PEDEVCO Corp. (NYSE American: PED), a public company engaged primarily in the acquisition, exploration, development and production of oil and natural gas shale plays in the US from May 2016 to May 2018. Mr. Peterson served as Chief Financial Officer of PEDEVCO between July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (PEDEVCO's predecessor) from July 2012 to October 2014, and as PEDEVCO's President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a director (from May 2006 to July 2012) of Aemetis, Inc. (formerly AE Biofuels Inc.), a Cupertino, California-based global advanced biofuels and renewable commodity chemicals company (NASDAQ: AMTX), and as Chairman and Chief Executive Officer of Nevo Energy, Inc. (NEVE) (formerly Solargen Energy, Inc.), a Cupertino, California-based developer of utility-scale solar farms which he helped form in December 2008 (from December 2008 to July 2012). From 2005 to 2006, Mr. Peterson served as a managing partner of American Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high-net-worth investors. From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs & Co. in a variety of positions and roles, including as a Vice President. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham Young University. - Michael L Peterson于2022年4月开始担任Lafayette Energy Corp.的总裁、首席执行官和董事会成员。自2021年9月起,Peterson先生担任Aesther Healthcare Acquisition Corp.(纳斯达克股票代码:AEHA)董事会、审计委员会(主席)、薪酬委员会、提名和公司治理委员会成员,该公司是一家与Ocean Biomedical公司(纳斯达克股票代码:OCEA)合并的特殊目的收购公司,并继续担任合并后公司的独立董事。自2022年12月起,Peterson先生还担任特殊目的收购公司Kernel Group Holdings, Inc.(纳斯达克股票代码:KRNL)的董事。自2023年3月起,Peterson先生还担任特殊目的收购公司OceanTech收购I Corp(纳斯达克股票代码:OTEC)的董事。彼得森自2020年12月起担任Nevo Motors,Inc.的总裁,该公司成立的目的是为重型电动汽车市场商业化增程发电机技术,但目前尚未投入运营。自2022年5月起,Peterson先生担任Trio Petroleum Corp.的董事会成员和审计委员会主席,Trio Petroleum Corp.是一家正在上市的石油和天然气勘探和开发公司,自2021年2月起,Peterson先生担任Indonesia Energy Corporation Limited(纽约证券交易所美国代码:INDO)的董事会成员和审计委员会主席。彼得森曾于2018年6月至2021年6月在台湾台北担任耶稣基督后期圣徒教会台北台湾传道会会长。Peterson先生于2016年8月至2021年5月担任TRxADE HEALTH公司(原Trxade Group, Inc.)董事会的独立成员(纳斯达克股票代码:MEDS)。彼得森先生于2016年5月至2018年5月担任PEDEVCO公司(纽约证券交易所美国代码:PED)的首席执行官,该公司是一家上市公司,主要从事石油和天然气页岩的收购、勘探、开发和生产。Peterson先生于2012年7月至2016年5月担任PEDEVCO的首席财务官,并于2012年7月至2014年10月担任太平洋能源开发公司(PEDEVCO的前身)的执行副总裁,并于2014年10月至2018年5月担任PEDEVCO的总裁。Peterson先生于2011年9月加入太平洋能源发展公司,担任执行副总裁,2012年6月担任首席财务官,并于2012年7月至2013年9月担任公司董事会成员。Peterson先生曾担任Pacific Energy Development的临时总裁兼首席执行官(2009年6月至2011年12月)和董事(2008年5月至2011年12月)、Aemetis, Inc.(原AE Biofuels Inc.)的董事(2006年5月至2012年7月),以及Nevo Energy,Inc.(NEVE)(原Solargen Energy,Inc.)的董事长兼首席执行官,Nevo Energy,Inc.是一家总部位于加利福尼亚州库比蒂诺的公用事业规模太阳能发电场开发商,他于2008年12月(2008年12月至2012年7月)帮助成立了这家公司。从2005年到2006年,彼得森先生担任美国机构伙伴公司的管理合伙人,这是一家设在盐湖城的风险投资基金。从2000年到2004年,他在美林担任第一副总裁,帮助建立了一个新的私人客户服务部门,专门与高净值投资者合作。1989年9月至2000年1月,Peterson先生受雇于高盛萨克斯公司,担任各种职务和职务,包括副总裁。Peterson先生在万豪酒店管理学院获得MBA学位,在杨百翰大学获得统计学/计算机科学学士学位。
- Michael L Peterson,commenced serving as President, Chief Executive Officer and as a member of the Board of Directors of Lafayette Energy Corp. in April 2022. Since September 2021, Mr. Peterson has served as a member of the Board of Directors, Audit Committee (Chair), Compensation Committee and Nominating and Corporate Governance Committee of Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA), a special purpose acquisition company which merged with Ocean Biomedical, Inc (NASDAQ: OCEA) and continues to serve as an independent director of the merged company. Since December 2022, Mr. Peterson has also served as a director of Kernel Group Holdings, Inc., a special purpose acquisition company (NASDAQ: KRNL). Since March 2023, Mr. Peterson has also served as a director of OceanTech Acquisition I Corp,a special purpose acquisition company (NASDAQ: OTEC). Mr. Peterson has served as the president of Nevo Motors, Inc. since December 2020, which was established to commercialize a range extender generator technology for the heavy-duty electric vehicle market but is currently non-operational. Since May 2022, Mr. Peterson has served as a member of the Board of Directors and as the Chairperson of the Audit Committee of Trio Petroleum Corp., an oil and gas exploration and development company which is in the process of going public, since February 2021, Mr. Peterson has served on the board of directors and as the Chairman of the Audit Committee of Indonesia Energy Corporation Limited (NYSE American: INDO). Mr. Peterson previously served as the president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan from June 2018 to June 2021. Mr. Peterson served as an independent member of the Board of Directors of TRxADE HEALTH, Inc. (formerly Trxade Group, Inc.) from August 2016 to May 2021 (NASDAQ: MEDS). Mr. Peterson served as the Chief Executive Officer of PEDEVCO Corp. (NYSE American: PED), a public company engaged primarily in the acquisition, exploration, development and production of oil and natural gas shale plays in the US from May 2016 to May 2018. Mr. Peterson served as Chief Financial Officer of PEDEVCO between July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (PEDEVCO's predecessor) from July 2012 to October 2014, and as PEDEVCO's President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a director (from May 2006 to July 2012) of Aemetis, Inc. (formerly AE Biofuels Inc.), a Cupertino, California-based global advanced biofuels and renewable commodity chemicals company (NASDAQ: AMTX), and as Chairman and Chief Executive Officer of Nevo Energy, Inc. (NEVE) (formerly Solargen Energy, Inc.), a Cupertino, California-based developer of utility-scale solar farms which he helped form in December 2008 (from December 2008 to July 2012). From 2005 to 2006, Mr. Peterson served as a managing partner of American Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high-net-worth investors. From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs & Co. in a variety of positions and roles, including as a Vice President. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham Young University.
- Jeff Newell
-
Jeff Newell,自2003年5月起,Newell先生担任医疗保健咨询公司The Newell Group LLC的首席执行官。在此之前的2017年至2021年,他担任医疗保健质量测量和报告公司Pharmacy Quality Solutions的首席执行官。他还曾担任零售药房Kmart Pharmacy/Sears Holding Corporation(2015-2017年)的药房管理副总裁,以及长期护理药房Millennium Long Term Care Pharmacy Systems(2012-2014年)的高级副总裁兼首席合规官。在此之前,他还担任过其他各种医疗保健管理职务,包括担任非营利医疗保健咨询集团Quality Partners Rhode Island的首席运营官(2003-2011年),担任过各种职务,包括药剂师、企业分析师、药剂师主管、经理和CVS药剂师项目主任(1982-2003年),以及纽约纽维尔大药房的共同所有人和药剂师(1980-1984年)。在整个职业生涯中,纽厄尔曾在医疗行业的许多国家、州和地方委员会任职。纽厄尔先生已经退休,通过他的咨询公司(纽厄尔集团有限责任公司)在行业内保持活跃。他为一些特定的公司和个人提供咨询,并利用他的专业知识和庞大的人脉网络来提高业绩。纽厄尔先生是美国药剂师协会和罗德岛药剂师协会的成员。他在奥尔巴尼药学与Health Sciences学院获得药学学士学位。
Jeff Newell,Since May 2003, Mr. Newell has served as the Chief Executive Officer of The Newell Group LLC, a healthcare consulting firm. Prior to that, from 2017 to 2021, he served as the Chief Executive Officer of Pharmacy Quality Solutions, a healthcare quality measuring and reporting company. He also previously served as the Vice President of Pharmacy Administration for Kmart Pharmacy/Sears Holding Corporation (2015-2017), a retail pharmacy and as Senior Vice President and Chief Compliance Officer for Millennium Long Term Care Pharmacy Systems (2012-2014), a long-term care pharmacy. Prior to that, he served in various other healthcare management roles, including serving as Chief Operating Officer of Quality Partners Rhode Island, a non-profit healthcare consulting group (2003-2011), in various roles, including as a Pharmacist, Corporate Analyst, Pharmacy Supervisor, Manager, and Director of Pharmacy Programs with CVS (1982-2003), and as a Co-Owner of, and Pharmacist with, Newell's Pharmacy in New York (1980-1984). Throughout his career, Mr. Newell has served on many National, State and Local Boards, within the Healthcare Industry. Mr. Newell is retired and stays active within the industry through his consulting company (The Newell Group LLC). He consults with a select number of companies and individuals and leverages his expertise and vast network to drive improved performance. Mr. Newell is a member of the American Pharmacist Association and Rhode Island Pharmacist Association. He received his Bachelor of Science degree in Pharmacy from Albany College of Pharmacy & Health Sciences. - Jeff Newell,自2003年5月起,Newell先生担任医疗保健咨询公司The Newell Group LLC的首席执行官。在此之前的2017年至2021年,他担任医疗保健质量测量和报告公司Pharmacy Quality Solutions的首席执行官。他还曾担任零售药房Kmart Pharmacy/Sears Holding Corporation(2015-2017年)的药房管理副总裁,以及长期护理药房Millennium Long Term Care Pharmacy Systems(2012-2014年)的高级副总裁兼首席合规官。在此之前,他还担任过其他各种医疗保健管理职务,包括担任非营利医疗保健咨询集团Quality Partners Rhode Island的首席运营官(2003-2011年),担任过各种职务,包括药剂师、企业分析师、药剂师主管、经理和CVS药剂师项目主任(1982-2003年),以及纽约纽维尔大药房的共同所有人和药剂师(1980-1984年)。在整个职业生涯中,纽厄尔曾在医疗行业的许多国家、州和地方委员会任职。纽厄尔先生已经退休,通过他的咨询公司(纽厄尔集团有限责任公司)在行业内保持活跃。他为一些特定的公司和个人提供咨询,并利用他的专业知识和庞大的人脉网络来提高业绩。纽厄尔先生是美国药剂师协会和罗德岛药剂师协会的成员。他在奥尔巴尼药学与Health Sciences学院获得药学学士学位。
- Jeff Newell,Since May 2003, Mr. Newell has served as the Chief Executive Officer of The Newell Group LLC, a healthcare consulting firm. Prior to that, from 2017 to 2021, he served as the Chief Executive Officer of Pharmacy Quality Solutions, a healthcare quality measuring and reporting company. He also previously served as the Vice President of Pharmacy Administration for Kmart Pharmacy/Sears Holding Corporation (2015-2017), a retail pharmacy and as Senior Vice President and Chief Compliance Officer for Millennium Long Term Care Pharmacy Systems (2012-2014), a long-term care pharmacy. Prior to that, he served in various other healthcare management roles, including serving as Chief Operating Officer of Quality Partners Rhode Island, a non-profit healthcare consulting group (2003-2011), in various roles, including as a Pharmacist, Corporate Analyst, Pharmacy Supervisor, Manager, and Director of Pharmacy Programs with CVS (1982-2003), and as a Co-Owner of, and Pharmacist with, Newell's Pharmacy in New York (1980-1984). Throughout his career, Mr. Newell has served on many National, State and Local Boards, within the Healthcare Industry. Mr. Newell is retired and stays active within the industry through his consulting company (The Newell Group LLC). He consults with a select number of companies and individuals and leverages his expertise and vast network to drive improved performance. Mr. Newell is a member of the American Pharmacist Association and Rhode Island Pharmacist Association. He received his Bachelor of Science degree in Pharmacy from Albany College of Pharmacy & Health Sciences.
高管简历
中英对照 |  中文 |  英文- Suren Ajjarapu
自招股说明书构成部分的注册声明生效之日起,Suren Ajjarapu一直担任我们的董事之一。Ajjarapu自2010年7月起担任TrxadeGroup,Inc.(NASDAQ:MEDS,特拉华州一家公司及其前身公司)董事长、首席执行官和秘书。自2018年3月以来,Ajjarapu先生一直担任Kano Energy Corp.的董事会执行主席,该公司参与了美国可再生天然气站点的开发。Ajjarapu先生是Sansur Renewable Energy,Inc.的创始人,并于2009年3月至2012年12月担任首席执行官兼董事会主席,Sansur Renewable Energy,Inc.是一家参与开发美国中西部风电站点的公司。Ajjarapu先生还从2006年1月到2009年3月担任Aemetis,Inc.(一家生物燃料公司,纳斯达克股票代码:AMTX)的创始人、总裁兼董事,以及International Biofuels(Aemetis,Inc.的一家子公司)的创始人、董事长兼首席执行官。Ajjarapu先生是Global Information Technology,Inc.的联合创始人,首席运营官兼董事,Global Information Technology,Inc.是一家IT外包和系统设计公司,总部位于佛罗里达州坦帕,在印度拥有主要业务。Ajjarapu先生毕业于南达科他州立大学,获得环境工程硕士学位,并毕业于南佛罗里达大学,获得国际金融和管理专业的工商管理硕士学位。Ajjarapu先生还是哈佛大学风险资本和私募股权计划的毕业生。
Suren Ajjarapu has served as Aesther Healthcare Acquisition Corp.'s Chairman and Chief Executive Officer since Aesther Healthcare Acquisition Corp.'s inception in June 2021. He has served as the Chairman of the Board, Chief Executive Officer and Secretary of TRxADE HEALTH, INC., formerly Trxade Group, Inc. NASDAQ:MEDS("TRxADE") since its acquisition of Trxade Group, Inc., a Nevada corporation ("Trxade Nevada") (Aesther Healthcare Acquisition Corp.'s predecessor company) on January 8 2014 and as the Chairman of the Board, Chief Executive Officer and Secretary of Trxade Nevada since its inception. Since March 2021 Mr. Ajjarapu has served on the Board of OceanTech Acquisitions I Corp., a Special Purpose Acquisition Company (SPAC)(NASDAQ:OTECU). Mr. Ajjarapu was a Founder, CEO and Chairman of Sansur Renewable Energy, Inc., a company involved in developing wind power sites in the Midwest, United States, from 2009 to 2012. Mr. Ajjarapu was a Founder, President and Director of Aemetis, Inc., a biofuels company (AMTX.OB) and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis, Inc., from 2006 to 2009. Mr. Ajjarapu was Co-Founder, COO, and Director Global Information Technology, Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India from 1995 to 2006. Mr. Ajjarapu holds an MS in Environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.- 自招股说明书构成部分的注册声明生效之日起,Suren Ajjarapu一直担任我们的董事之一。Ajjarapu自2010年7月起担任TrxadeGroup,Inc.(NASDAQ:MEDS,特拉华州一家公司及其前身公司)董事长、首席执行官和秘书。自2018年3月以来,Ajjarapu先生一直担任Kano Energy Corp.的董事会执行主席,该公司参与了美国可再生天然气站点的开发。Ajjarapu先生是Sansur Renewable Energy,Inc.的创始人,并于2009年3月至2012年12月担任首席执行官兼董事会主席,Sansur Renewable Energy,Inc.是一家参与开发美国中西部风电站点的公司。Ajjarapu先生还从2006年1月到2009年3月担任Aemetis,Inc.(一家生物燃料公司,纳斯达克股票代码:AMTX)的创始人、总裁兼董事,以及International Biofuels(Aemetis,Inc.的一家子公司)的创始人、董事长兼首席执行官。Ajjarapu先生是Global Information Technology,Inc.的联合创始人,首席运营官兼董事,Global Information Technology,Inc.是一家IT外包和系统设计公司,总部位于佛罗里达州坦帕,在印度拥有主要业务。Ajjarapu先生毕业于南达科他州立大学,获得环境工程硕士学位,并毕业于南佛罗里达大学,获得国际金融和管理专业的工商管理硕士学位。Ajjarapu先生还是哈佛大学风险资本和私募股权计划的毕业生。
- Suren Ajjarapu has served as Aesther Healthcare Acquisition Corp.'s Chairman and Chief Executive Officer since Aesther Healthcare Acquisition Corp.'s inception in June 2021. He has served as the Chairman of the Board, Chief Executive Officer and Secretary of TRxADE HEALTH, INC., formerly Trxade Group, Inc. NASDAQ:MEDS("TRxADE") since its acquisition of Trxade Group, Inc., a Nevada corporation ("Trxade Nevada") (Aesther Healthcare Acquisition Corp.'s predecessor company) on January 8 2014 and as the Chairman of the Board, Chief Executive Officer and Secretary of Trxade Nevada since its inception. Since March 2021 Mr. Ajjarapu has served on the Board of OceanTech Acquisitions I Corp., a Special Purpose Acquisition Company (SPAC)(NASDAQ:OTECU). Mr. Ajjarapu was a Founder, CEO and Chairman of Sansur Renewable Energy, Inc., a company involved in developing wind power sites in the Midwest, United States, from 2009 to 2012. Mr. Ajjarapu was a Founder, President and Director of Aemetis, Inc., a biofuels company (AMTX.OB) and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis, Inc., from 2006 to 2009. Mr. Ajjarapu was Co-Founder, COO, and Director Global Information Technology, Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India from 1995 to 2006. Mr. Ajjarapu holds an MS in Environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
- Prashant Patel
Prashant Patel,自Trxade Health,Inc.于2014年1月8日收购TRxADE Nevada以来,一直担任Trxade Health,Inc.的全职总裁兼首席运营官和董事。帕特尔先生是一名注册药剂师和制药顾问,在零售药房和医药物流领域拥有20多年的经验,是佛罗里达州坦帕湾地区几家药房的创始人。Patel先生自2010年8月起担任Trxade Nevada总裁兼董事会成员。自2008年10月以来,帕特尔先生一直担任制药公司APAA LLC的管理成员和制药逆向分销商Pharmaceutical Returns Of America LLC的首席执行官。Patel先生毕业于诺丁汉大学药学院,在联合王国执业,之后在联合王国城市大学卡斯商学院获得运输、贸易和金融硕士学位。
Prashant Patel,has served as Trxade Health, Inc. full-time President and Chief Operating Officer, and as a director since Trxade Health, Inc. acquisition of TRxADE Nevada on January 8, 2014. Effective March 6, 2023, Mr. Patel, was appointed as Interim Principal Financial/Accounting Officer of the Company following Ms. Janet Huffman's notification to the Company on February 27, 2023, of the termination of her Offer Letter dated February 3, 2022. Mr. Patel is a registered pharmacist and pharmaceutical consultant with over twenty years of experience in retail pharmacy and pharmaceutical logistics, and the founder of several pharmacies in the Tampa Bay, Florida area. Mr. Patel has been President and Member of Board of Trxade Nevada since August 2010. Since October 2008, Mr. Patel has been Managing Member of APAA LLC, a pharmacy and CEO of Pharmaceutical Returns Of America LLC, a pharmaceutical reverse distributor. Mr. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, United Kingdom.- Prashant Patel,自Trxade Health,Inc.于2014年1月8日收购TRxADE Nevada以来,一直担任Trxade Health,Inc.的全职总裁兼首席运营官和董事。帕特尔先生是一名注册药剂师和制药顾问,在零售药房和医药物流领域拥有20多年的经验,是佛罗里达州坦帕湾地区几家药房的创始人。Patel先生自2010年8月起担任Trxade Nevada总裁兼董事会成员。自2008年10月以来,帕特尔先生一直担任制药公司APAA LLC的管理成员和制药逆向分销商Pharmaceutical Returns Of America LLC的首席执行官。Patel先生毕业于诺丁汉大学药学院,在联合王国执业,之后在联合王国城市大学卡斯商学院获得运输、贸易和金融硕士学位。
- Prashant Patel,has served as Trxade Health, Inc. full-time President and Chief Operating Officer, and as a director since Trxade Health, Inc. acquisition of TRxADE Nevada on January 8, 2014. Effective March 6, 2023, Mr. Patel, was appointed as Interim Principal Financial/Accounting Officer of the Company following Ms. Janet Huffman's notification to the Company on February 27, 2023, of the termination of her Offer Letter dated February 3, 2022. Mr. Patel is a registered pharmacist and pharmaceutical consultant with over twenty years of experience in retail pharmacy and pharmaceutical logistics, and the founder of several pharmacies in the Tampa Bay, Florida area. Mr. Patel has been President and Member of Board of Trxade Nevada since August 2010. Since October 2008, Mr. Patel has been Managing Member of APAA LLC, a pharmacy and CEO of Pharmaceutical Returns Of America LLC, a pharmaceutical reverse distributor. Mr. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, United Kingdom.